Benzyl alpha-D-threo-hexopyranoside | 34246-23-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Benzyl alpha-D-threo-hexopyranoside
• 英文别名: (3S,4S,6S)-2-(hydroxymethyl)-6-phenylmethoxyoxane-3,4,5-triol
• CAS: 34246-23-6
• 化学式: C₁₃H₁₈O₆
• 分子量: 270.28
• InChiKey: GKHCBYYBLTXYEV-DRYUAMBJSA-N

物化性质

• 熔点：
  111-112°C
• 沸点：
  480.2±45.0 °C(Predicted)
• 密度：
  1.40±0.1 g/cm3(Predicted)
• 溶解度：
  可微溶于水

计算性质

• 辛醇/水分配系数(LogP)：
  -0.7
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  99.4
• 氢给体数：
  4
• 氢受体数：
  6

安全信息

• 海关编码：
  2932999099

文献信息

• CELLULOSE SUPPORT CONTAINING D-MANNOSE DERIVATIVES
  申请人：Dufour Menno

  公开号：US20120100097A1

  公开（公告）日：2012-04-26

  Cellulose support containing mannose derivatives able to fix type 1 piliated bacteria, application to disinfecting wipes especially. Support intended to bind type 1 piliated bacteria comprising cellulose fibers and/or regenerated cellulose fibers onto which mannose derivative is fixed characterized in that the mannose derivative is present in the form of copolymer obtained by copolymerization of: —a monomer derivative of alkenyl α-D-mannopyranoside modified with a function capable of reacting with an acrylamid monomer, —a cationic monomer —an acrylamid monomer.

  含有甘露糖衍生物的纤维素支持能够固定第1型纤毛细菌，适用于消毒湿巾。所述支持旨在结合含有纤维素纤维和/或再生纤维素纤维的第1型纤毛细菌，其中甘露糖衍生物被固定，其特征在于甘露糖衍生物以以下方式共聚获得：-一种烯基α-D-甘露糖苷衍生物单体，其经改性具有能够与丙烯酰胺单体发生反应的功能，-一种阳离子单体- 丙烯酰胺单体。
• MANNOSE DERIVATIVES AS ANTAGONISTS OF BACTERIAL ADHESION
  申请人：Ernst Beat

  公开号：US20120270824A1

  公开（公告）日：2012-10-25

  Compounds of the formula (I) wherein n is 0, 1 or 2, R 1 is aryl, heteroaryl or heterocyclyl, and R 2 and R 3 are hydrogen or a substituent as described in the specification, are useful for the prevention and treatment of bacterial infections, in particular of urinary infections caused by E. coli .

  式(I)的化合物，其中n为0、1或2，R1为芳基、杂芳基或杂环基，R2和R3为氢或规范中所述的取代基，对于预防和治疗细菌感染，特别是由大肠杆菌引起的尿路感染是有用的。
• TREATMENT OF URINARY TRACT INFECTION
  申请人：BIOMEDICALS SWEDEN AB

  公开号：US20170173058A1

  公开（公告）日：2017-06-22

  The embodiments relate to compositions useful in the treatment, inhibition or prevention of urinary tract infection in a subject. The compositions comprise a pH increasing agent, a pH decreasing agent and man nose or an analogue thereof. The pH increasing agent and the pH decreasing agent are provided to be alternately administered to the subject.